C‑type lectins facilitate tumor metastasis (Review)
- Authors:
- Dongbing Ding
- Yao Yao
- Songbai Zhang
- Chunjie Su
- Yonglian Zhang
-
Affiliations: Department of Gastrointestinal Surgery, Jingmen First People's Hospital, Jingmen, Hubei 448000, P.R. China, Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China - Published online on: November 24, 2016 https://doi.org/10.3892/ol.2016.5431
- Pages: 13-21
-
Copyright: © Ding et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2:563–572. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Alitalo K, Tammela T and Petrova TV: Lymphangiogenesis in development and human disease. Nature. 438:946–953. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fidler IJ: The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 3:453–458. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Läubli H and Borsig L: Selectins promote tumor metastasis. Semin Cancer Biol. 20:169–177. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Arabzadeh A, Chan C, Nouvion AL, Breton V, Benlolo S, DeMarte L, Turbide C, Brodt P, Ferri L and Beauchemin N: Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer. Oncogene. 32:849–860. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Desgrosellier JS and Cheresh DA: Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer. 10:9–22. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
van Gisbergen KP, Aarnoudse CA, Meijer GA, Geijtenbeek TB and van Kooyk Y: Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res. 65:5935–5944. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang Y, Zhang C, Chen K, Chen Z, Sun Z, Zhang Z, Ding D, Ren S and Zuo Y: The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer. PLoS One. 9:e1147482014. View Article : Google Scholar : PubMed/NCBI | |
|
Zuo Y, Ren S, Wang M, Liu B, Yang J, Kuai X, Lin C, Zhao D, Tang L and He F: Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in vivo metastasis to the liver. Gut. 62:1169–1178. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kannagi R, Izawa M, Koike T, Miyazaki K and Kimura N: Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 95:377–384. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Feinberg H, Mitchell DA, Drickamer K and Weis WI: Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science. 294:2163–2166. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kansas GS: Selectins and their ligands: Current concepts and controversies. Blood. 88:3259–3287. 1996.PubMed/NCBI | |
|
Martinez-Pomares L: The mannose receptor. J Leukoc Biol. 92:1177–1186. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mitchell DA, Fadden AJ and Drickamer K: A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem. 276:28939–28945. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Zarbock A, Ley K, McEver RP and Hidalgo A: Leukocyte ligands for endothelial selectins: Specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 118:6743–6751. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pals ST, de Gorter DJ and Spaargaren M: Lymphoma dissemination: The other face of lymphocyte homing. Blood. 110:3102–3111. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Qian F, Hanahan D and Weissman IL: L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc Natl Acad Sci USA. 98:3976–3981. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Sperandio M: Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J. 273:4377–4389. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Girard JP, Moussion C and Förster R: HEV, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol. 12:762–773. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Irjala H, Johansson EL, Grenman R, Alanen K, Salmi M and Jalkanen S: Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med. 194:1033–1042. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Zuo Y, Wei W, Liu C, Zhao L, Wang L and Zhang J: Silencing L-selectin expression by siRNA attenuated metastasis of murine lymphoid neoplasm cell P388D1 to peripheral lymph nodes. Leukemia. 21:180–183. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wei W, Zuo Y, Hu Y, Wang L, Jia L and Zhang J: Heparin inhibits P388D1 cells adherence and metastasis to peripheral lymph nodes in vitro and in vivo. Lymphology. 42:10–18. 2009.PubMed/NCBI | |
|
Aviram R, Raz N, Kukulansky T and Hollander N: Expression of L-selectin and efficient binding to high endothelial venules do not modulate the dissemination potential of murine B-cell lymphoma. Cancer Immunol Immunother. 50:61–68. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Wei J, Cui L, Liu F, Fan Y, Lang R, Gu F, Guo X, Tang P and Fu L: E-selectin and Sialyl Lewis X expression is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Int J Surg Pathol. 18:193–200. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gay LJ and Felding-Habermann B: Contribution of platelets to tumour metastasis. Nat Rev Cancer. 11:123–134. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gout S, Tremblay PL and Huot J: Selectins and selectin ligands in extravasation of cancer cells and organs electivity of metastasis. Clin Exp Metastasis. 25:335–344. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tomlinson J, Wang JL, Barsky SH, Lee MC, Bischoff J and Nguyen M: Human colon cancer cells express multiple glycoprotein ligands for E-selecin. Int J Oncol. 16:347–353. 2000.PubMed/NCBI | |
|
Khatib AM, Fallavollita L, Wancewicz EV, Monia BP and Brodt P: Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res. 62:5393–5398. 2002.PubMed/NCBI | |
|
Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S and Brodt P: Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res. 59:1356–1361. 1999.PubMed/NCBI | |
|
Hanley WD, Burdick MM, Konstantopoulos K and Sackstein R: CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Res. 65:5812–5817. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Burdick MM, Chu JT, Godar S and Sackstein R: HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem. 281:13899–13905. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR and Wolitzky BA: Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer. 71:612–619. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Köhler S, Ullrich S, Richter U and Schumacher U: E-/P-selectins and colon carcinoma metastasis: First in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. Br J Cancer. 102:602–609. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zen K, Liu DQ, Guo YL, Wang C, Shan J, Fang M, Zhang CY and Liu Y: CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One. 3:e18262008. View Article : Google Scholar : PubMed/NCBI | |
|
Shirure VS, Henson KA, Schnaar RL, Nimrichter L and Burdick MM: Gangliosiedes expressed on breast cancer cells are E-selectin ligands. Biochem Biophys Res Commun. 406:423–429. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Shirure VS, Reynolds NM and Burdick MM: Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cell. PLoS One. 7:e445292012. View Article : Google Scholar : PubMed/NCBI | |
|
Dimitroff CJ, Lechpammer M, Long-Woodward D and Kutok JL: Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res. 64:5261–5269. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshimoto K, Tajima H, Ohta T, Okamoto K, Sakai S, Kinoshita J, Furukawa H, Makino I, Hayashi H, Nakamura K, et al: Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer. Oncol Rep. 28:791–796. 2012.PubMed/NCBI | |
|
Kobayashi K, Matsumoto S, Morishima T, Kawabe T and Okamoto T: Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res. 60:3978–3984. 2000.PubMed/NCBI | |
|
Raes G, Ghassabeh GH, Brys L, Mpofu N, Verschueren H, Vanhecke D and De Baetselier P: The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomas. Int J Cancer. 121:2646–2652. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar M and Altevogt P: CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood. 89:3385–3395. 1997.PubMed/NCBI | |
|
Alves CS, Burdick MM, Thomas SN, Pawar P and Konstantopoulos K: The dual role of CD44 as a functional P selectin ligand and fibrin receptor in colon carcinoma cell adhesion. Am J Physiol Cell Physiol. 294:C907–C916. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Garcia J, Callewaert N and Borsig L: P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. Glycobiology. 17:185–196. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Monzavi-Karbassi B, Stanley JS, Hennings L, Jousheghany F, Artaud C, Shaaf S and Kieber-Emmons T: Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer. 120:1179–1191. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Stone JP and Wagner DD: P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest. 92:804–813. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Ludwig RJ, Boehme B, Podda M, Henschler R, Jager E, Tandi C, Boehncke WH, Zollner TM, Kaufmann R and Gille J: Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res. 64:2743–2750. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kim YJ, Borsig L, Varki NM and Varki A: P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA. 95:9325–9330. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JL, Chen WX, Zhu JS, Chen NW, Zhou T, Yao M, Zhang DQ and Wu YL: Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function. World J Gastroenterol. 9:1607–1610. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Wei M, Tai G, Gao Y, Li N, Huang B, Zhou Y, Hao S and Zeng X: Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions. J Biol Chem. 279:29202–29210. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y, Wei M, Zheng S, Ba X, Hao S and Zeng X: Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin. J Cancer Res Clin Oncol. 132:257–264. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Borsig L, Vlodavsky I, Ishai-Michaeli R, Torri G and Vismara E: Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase. Neoplasia. 13:445–452. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sperandio M, Smith ML, Forlow SB, Olson TS, Xia L, McEver RP and Ley K: P-selectin glycoprotein ligand-1 mediates L-selectin dependent leukocyte rolling in venules. J Exp Med. 197:1355–1363. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Läubli H, Stevenson JL, Varki A, Varki NM and Borsig L: L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. Cancer Res. 66:1536–1542. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Borsig L, Wong R, Hynes RO, Varki NM and Varki A: Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA. 99:2193–2198. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Dallas MR, Chen SH, Streppel MM, Sharma S, Maitra A and Konstantopoulos K: Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells. Am J Physiol Cell Physiol. 303:C616–C624. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R and Konstantopoulos K: Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. FASEB J. 20:337–339. 2006.PubMed/NCBI | |
|
Thomas SN, Zhu F, Schnaar RL, Alves CS and Konstantopoulos K: Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem. 283:15647–15655. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Rivera-Calzada A, Robertson D, MacFadyen JR, Boskovic J, Isacke CM and Llorca O: Three-dimensional interplay among the ligand-binding domains of the urokinase-plasminogen-activator-receptor-associated protein, Endo180. EMBO Rep. 4:807–812. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Jürgensen HJ, Madsen DH, Ingvarsen S, Melander MC, Gårdsvoll H, Patthy L, Engelholm LH and Behrendt N: A novel functional role of collagen glycosylation: Interaction with the endocytic receptor uPARAP/Endo180. J Biol Chem. 286:32736–32748. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Irjala H, Alanen K, Grénman R, Heikkilä P, Joensuu H and Jalkanen S: Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res. 63:4671–4676. 2003.PubMed/NCBI | |
|
Marttila-Ichihara F, Turja R, Miiluniemi M, Karikoski M, Maksimow M, Niemelä J, Martinez-Pomares L, Salmi M and Jalkanen S: Macrophage mannose receptor on lymphatics controls cell trafficking. Blood. 112:64–72. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Salmi M, Karikoski M, Elima K, Rantakari P and Jalkanen S: CD44 binds to macrophage mannose receptor on lymphatic endothelium and supports lymphocyte migration via afferent lymphatics. Circ Res. 112:1577–1582. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Götte M and Yip GW: Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective. Cancer Res. 66:10233–10237. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Wielenga VJ, van der Neut R, Offerhaus GJ and Pals ST: CD44 glycoproteins in colorectal cancer: Expression, function, and prognostic value. Adv Cancer Res. 77:169–187. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI | |
|
Jürgensen HJ, Madsen DH, Ingvarsen S, Melander MC, Gårdsvoll H, Patthy L, Engelholm LH and Behrendt N: A novel functional role of collagen glycosylation: Interraction with the endocytic collagen receptor uPARAP/ENDO180. J Biol Chem. 286:32736–32748. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kogianni G, Walker MM, Waxman J and Sturge J: Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression. Eur J Cancer. 45:685–693. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Sulek J, Wagenaar-Miller RA, Shireman J, Molinolo A, Madsen DH, Engelholm LH, Behrendt N and Bugge TH: Increased expression of the collagen internalization receptor uPARAP/Endo180 in the stroma of head and neck cancer. J Histochem Cytochem. 55:347–353. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wienke D, Davies GC, Johnson DA, Sturge J, Lambros MB, Savage K, Elsheikh SE, Green AR, Ellis IO, Robertson D, et al: The collagen receptor Endo180 (CD280) is expressed on basal-like breast tumor cells and promotes tumor growth in vivo. Cancer Res. 67:10230–10240. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Huijbers IJ, Iravani M, Popov S, Robertson D, Al-Sarraj S, Jones C and Isacke CM: A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion. PLoS One. 5:e98082010. View Article : Google Scholar : PubMed/NCBI | |
|
Engelholm LH, Ingvarsen S, Jürgensen HJ, Hillig T, Madsen DH, Nielsen BS and Behrendt N: The collagen receptor uPARAP/Endo180. Front Biosci (Landmark Ed). 14:2103–2114. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Curino AC, Engelholm LH, Yamada SS, Holmbeck K, Lund LR, Molinolo AA, Behrendt N, Nielsen BS and Bugge TH: Intracelluar collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy. J Cell Biol. 169:977–985. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Palmieri C, Caley MP, Purshouse K, Fonseca AV, Rodriguez-Teja M, Kogianni G, Woodley L, Odendaal J, Elliott K, Waxman J and Sturge J: Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer. Br J Cancer. 108:163–169. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Takahashi S, Yamada-Okabe H, Hamada K, Ohta S, Kawase T, Yoshida K and Toda M: Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells. J Neurooncol. 103:267–276. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
George JN: Platelets. Lancet. 355:1531–1539. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Takagi S, Sato S, Oh-hara T, Takami M, Koike S, Mishima Y, Hatake K and Fujita N: Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2. PLoS One. 8:e736092013. View Article : Google Scholar : PubMed/NCBI | |
|
Lowe KL, Finney BA, Deppermann C, Hägerling R, Gazit SL, Frampton J, Buckley C, Camerer E, Nieswandt B, Kiefer F and Watson SP: Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development. Blood. 125:3769–3777. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lowe KL, Navarro-Nunez L and Watson SP: Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb Res. 129:(Suppl 1). S30–S37. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Martín-Villar E, Scholl FG, Gamallo C, Yurrita MM, Muñoz-Guerra M, Cruces J and Quintanilla M: Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer. 113:899–910. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Rodrigo JP, Garcia-Carracedo D, González MV, Mancebo G, Fresno MF and García-Pedrero J: Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas. Mol Cancer. 9:482010. View Article : Google Scholar : PubMed/NCBI | |
|
Kato Y, Kaneko M, Sata M, Fujita N, Tsuruo T and Osawa M: Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma. Tumour Biol. 26:195–200. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kimura N and Kimura I: Podoplanin as a marker for mesothelioma. Pathol Int. 55:83–86. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kato Y, Fujita N, Kunita A, Sato S, Kaneko M, Osawa M and Tsuruo T: Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. J Biol Chem. 278:51599–51605. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Mishima K, Kato Y, Kaneko MK, Nishikawa R, Hirose T and Matsutani M: Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Acta Neuropathol. 111:483–488. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Liang M, Zhang P and Fu J: Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Letters. 258:31–37. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F, Ren S and Zuo Y: DC-SIGN, DC-SIGNR and LSECtin: C-Type Lectins for Infection. Int Rev Immunol. 33:54–66. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Nonaka M, Ma BY, Murai R, Nakamura N, Baba M, Kawasaki N, Hodohara K, Asano S and Kawasaki T: Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells. J Immunol. 180:3347–3356. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Xu F, Liu J, Liu D, Liu B, Wang M, Hu Z, Du X, Tang L and He F: LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses. Cancer Res. 74:3418–3428. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Chen K, Yan L, Yang Z, Zhu Z, Chen C, Zeng J, Wei W, Qi X, Ren S and Zuo Y: Low expression of dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein in non-Hodgkin lymphoma and significant correlations with lactic acid dehydrogenase and β2-microglobulin. Biochem Cell Biol. 91:214–220. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Keler T, Ramakrishna V and Fanger MW: Mannose receptor-targeted vaccines. Expert Opin Biol Ther. 4:1953–1962. 2004. View Article : Google Scholar : PubMed/NCBI |
